Cargando…
COVID-19 Disease and SARS-CoV-2 Vaccination in Patients with Cancer
Autores principales: | King, Daniel A., Chi, Jeffrey, Goyal, Shreya Prasad, Saif, M. Wasif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336091/ https://www.ncbi.nlm.nih.gov/pubmed/34355214 http://dx.doi.org/10.33696/pharmacol.3.020 |
Ejemplares similares
-
Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients
aged 65 years or older with advanced pancreatic cancer
por: Rehman, Hasan, et al.
Publicado: (2020) -
SARS-CoV-2 rS (NVX-CoV-2373) vaccine for prevention of COVID-19
Publicado: (2022) -
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022) -
SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
por: Velikova, Tsvetelina, et al.
Publicado: (2021) -
Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19
por: Yeaman, Michael R.
Publicado: (2021)